ABOUT US

ABOUT US


Despite major progress over the last 50 years (80% of young people with malignancy are disease free at 5 years after diagnosis), cancer remains the most common cause of death by disease beyond the age of one.


"There is a need to accelerate the process of evaluating innovative therapies and introducing them in standard cancer care in children and adolescents." Gilles Vassal, ACCELERATE Chair

Find out more

ACCELERATE is unique:

It guarantees the involvement of the four stakeholder groups (academia, patient advocates, industry and regulators) as equal partners

It Is patient-centred and problem-solving

It is international, having more than thousand experts and advocates having participated in its initiatives

Find out more

Governance


Learn more about our Leadership and the Team of ACCELERATE

Find out more

Sponsors & Testimonials


Find out more
Share by: